Limestone Capital Q&A


Benjamin Habbel, managing partner and co-founder, Limestone Capital, talks to us about the fund’s investment plans.

Has the possibility of a vaccine cut the likelihood of distressed opportunities?

“I don’t think that the arrival of the vaccine takes away the opportunity whatsoever, if anything it encourages investors to take chances now that there’s a small light at the end of the tunnel. We had factored in from day one that there would be many treatments. If sellers want to sell they

Nothing like a good cliffhanger… care to see how the story ends?

Register with your activation code to access this story.